Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ebolavirus"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 2113
Tytuł:
Computational and stability analysis of Ebola virus epidemic model with piecewise hybrid fractional operator.
Autorzy:
Nisar KS; Department of Mathematics, College of Arts and Sciences, Prince Sattam bin Abdulaziz University, Wadi Aldawaser, Saudi Arabia.
Farman M; Faculty of Arts and Sciences, Department of Mathematics, Near East University, Nicosia, Northern Cyprus, Turkey.; Department of Computer Science and Mathematics, Lebanese American University, Beirut, Lebanon.
Jamil K; Institute of Mathematics, Khwaja Fareed University of Engineering and Information Technology, Rahim Yar Khan, Pakistan.
Akgul A; Faculty of Arts and Science, Department of Mathematics, Siirt University, Siirt, Turkey.
Jamil S; Institute of Mathematics, Khwaja Fareed University of Engineering and Information Technology, Rahim Yar Khan, Pakistan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0298620. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Ebolavirus*
Hemorrhagic Fever, Ebola*/epidemiology
Epidemics*
Humans ; Learning ; Public Health
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
Autorzy:
Wirchnianski AS; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
Nyakatura EK; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Herbert AS; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.
Kuehne AI; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.
Abbasi SA; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.
Florez C; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.; The Geneva Foundation, Tacoma, Washington, United States of America.
Storm N; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.
McKay LGA; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Dailey L; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Kuang E; Mapp Biopharmaceutical Inc., San Diego, California, United States of America.
Abelson DM; Mapp Biopharmaceutical Inc., San Diego, California, United States of America.
Wec AZ; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
Chakraborti S; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Holtsberg FW; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America.
Shulenin S; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America.
Bornholdt ZA; Mapp Biopharmaceutical Inc., San Diego, California, United States of America.
Aman MJ; Integrated BioTherapeutics, Inc., Rockville, Maryland, United States of America.
Honko AN; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Griffiths A; Department of Virology, Immunology, and Microbiology; and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.
Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, New York, United States of America.
Lai JR; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Apr 11; Vol. 20 (4), pp. e1012134. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Bispecific*/immunology
Antibodies, Bispecific*/pharmacology
Antibodies, Bispecific*/therapeutic use
Ebolavirus*/immunology
Hemorrhagic Fever, Ebola*/immunology
Hemorrhagic Fever, Ebola*/prevention & control
Hemorrhagic Fever, Ebola*/virology
Antibodies, Viral*/immunology
Animals ; Mice ; Humans ; Filoviridae/immunology ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/therapeutic use ; Antibodies, Monoclonal/immunology ; Female ; Mice, Inbred BALB C ; Filoviridae Infections/immunology ; Filoviridae Infections/therapy ; Filoviridae Infections/prevention & control
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Geographic Disparities in Domestic Pig Population Exposure to Ebola Viruses, Guinea, 2017-2019.
Autorzy:
Grayo S
Camara A
Doukouré B
Ellis I
Troupin C
Fischer K
Vanhomwegen J
White M
Groschup MH
Diederich S
Tordo N
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 681-690.
Typ publikacji:
Journal Article
MeSH Terms:
Ebolavirus*
Hemorrhagic Fever, Ebola*/epidemiology
Hemorrhagic Fever, Ebola*/veterinary
Humans ; Swine ; Animals ; Guinea/epidemiology ; Sus scrofa ; Sierra Leone/epidemiology ; Nucleoproteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions .
Autorzy:
Bus-Jacobs L
Lau R
Soethoudt M
Gebbia L
Janssens E
Hermans T
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 757-760.
Typ publikacji:
Journal Article
MeSH Terms:
Ebola Vaccines*
Hemorrhagic Fever, Ebola*/prevention & control
Ebolavirus*
Humans ; Vibration ; Computer Simulation ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Ebola virus disease sequelae and viral persistence in animal models: Implications for the future.
Autorzy:
Durant O; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Mar 21; Vol. 20 (3), pp. e1012065. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*
Ebolavirus*
Animals ; Disease Outbreaks ; Disease Progression ; Disease Models, Animal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluating the risk of conflict on recent Ebola outbreaks in Guinea and the Democratic Republic of the Congo.
Autorzy:
Charnley GEC; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA. .; School of Public Health, Imperial College London, London, UK. .; Institute for Global Health, University College London, London, UK. .
Green N; Department of Statistical Science, University College London, London, UK.
Kelman I; Institute for Global Health, University College London, London, UK.; Institute for Risk and Disaster Reduction, University College London, London, UK.; University of Agder, Kristiansand, Norway.
Malembaka EB; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA.; Centre for Tropical Diseases and Global Health (CTDGH), Université Catholique de Bukavu, Bukavu, Democratic Republic of the Congo.
Gaythorpe KAM; School of Public Health, Imperial College London, London, UK.; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Mar 20; Vol. 24 (1), pp. 860. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*/epidemiology
Hemorrhagic Fever, Ebola*/prevention & control
Ebolavirus*
Humans ; Democratic Republic of the Congo/epidemiology ; Guinea/epidemiology ; Disease Outbreaks/prevention & control
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Recent advances in the treatment of Ebola disease: A brief overview.
Autorzy:
El Ayoubi LW; Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Mahmoud O; Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
Zakhour J; Internal Medicine Department, Henry Ford Hospital, Detroit, Michigan, United States of America.
Kanj SS; Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.; Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Mar 15; Vol. 20 (3), pp. e1012038. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Typ publikacji:
Review; Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*/epidemiology
Hemorrhagic Fever, Ebola*/prevention & control
Ebola Vaccines*
Ebolavirus*/genetics
Viral Vaccines*
Humans ; Antibodies, Viral ; Antibodies, Monoclonal/therapeutic use ; Uganda/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus .
Autorzy:
Cross RW; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Woolsey C; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Chu VC; Gilead Sciences, Inc., Foster City, CA, USA.
Babusis D; Gilead Sciences, Inc., Foster City, CA, USA.
Bannister R; Gilead Sciences, Inc., Foster City, CA, USA.
Vermillion MS; Gilead Sciences, Inc., Foster City, CA, USA.
Geleziunas R; Gilead Sciences, Inc., Foster City, CA, USA.
Barrett KT; Gilead Sciences, Inc., Foster City, CA, USA.
Bunyan E; Gilead Sciences, Inc., Foster City, CA, USA.
Nguyen AQ; Gilead Sciences, Inc., Foster City, CA, USA.
Cihlar T; Gilead Sciences, Inc., Foster City, CA, USA.
Porter DP; Gilead Sciences, Inc., Foster City, CA, USA.
Prasad AN; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Deer DJ; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Borisevich V; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Agans KN; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Martinez J; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Harrison MB; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Dobias NS; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Fenton KA; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Bilello JP; Gilead Sciences, Inc., Foster City, CA, USA.
Geisbert TW; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. eadk6176. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Ebolavirus*/drug effects
Hemorrhagic Fever, Ebola*/drug therapy
Hemorrhagic Fever, Ebola*/prevention & control
Nucleosides*/administration & dosage
Nucleosides*/pharmacology
Alanine*/administration & dosage
Alanine*/analogs & derivatives
Alanine*/pharmacology
Prodrugs*/administration & dosage
Prodrugs*/pharmacology
Antiviral Agents*/administration & dosage
Antiviral Agents*/pharmacology
Animals ; Administration, Oral ; Macaca fascicularis ; Adenosine Monophosphate/administration & dosage ; Adenosine Monophosphate/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An oral antiviral for Ebola disease.
Autorzy:
Sprecher A; Médecins Sans Frontières, Brussels, Belgium.
Van Herp M; Médecins Sans Frontières, Brussels, Belgium.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. 1181-1182. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents*/administration & dosage
Antiviral Agents*/pharmacology
Ebolavirus*/drug effects
Hemorrhagic Fever, Ebola*/drug therapy
Prodrugs*/administration & dosage
Prodrugs*/pharmacology
Humans ; Administration, Oral ; Animals
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ebola virus VP35 interacts non-covalently with ubiquitin chains to promote viral replication.
Autorzy:
Rodríguez-Salazar CA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.; Molecular Biology and Virology Laboratory, Faculty of Medicine and Health Sciences, Corporación Universitaria Empresarial Alexander von Humboldt, Armenia, Colombia.
van Tol S; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Mailhot O; Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Gonzalez-Orozco M; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Galdino GT; Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Warren AN; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.; Center for Virus-Host-Innate Immunity and Department of Medicine; Rutgers Biomedical and Health Sciences, Institute for Infectious and Inflammatory Diseases, Rutgers University, Newark, New Jersey, United States of America.
Teruel N; Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Behera P; Center for Virus-Host-Innate Immunity and Department of Medicine; Rutgers Biomedical and Health Sciences, Institute for Infectious and Inflammatory Diseases, Rutgers University, Newark, New Jersey, United States of America.
Afreen KS; Center for Virus-Host-Innate Immunity and Department of Medicine; Rutgers Biomedical and Health Sciences, Institute for Infectious and Inflammatory Diseases, Rutgers University, Newark, New Jersey, United States of America.
Zhang L; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Juelich TL; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Smith JK; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Zylber MI; Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Freiberg AN; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Najmanovich RJ; Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Canada.
Giraldo MI; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Rajsbaum R; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.; Center for Virus-Host-Innate Immunity and Department of Medicine; Rutgers Biomedical and Health Sciences, Institute for Infectious and Inflammatory Diseases, Rutgers University, Newark, New Jersey, United States of America.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2024 Feb 29; Vol. 22 (2), pp. e3002544. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*
Ebolavirus*/genetics
Nucleocapsid Proteins*
Humans ; Animals ; Mice ; Viral Regulatory and Accessory Proteins ; Ubiquitin ; Virus Replication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bivalent VSV Vectors Mediate Rapid and Potent Protection from Andes Virus Challenge in Hamsters.
Autorzy:
Marceau J; Laboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.; Department of Biomedical and Pharmaceutical Sciences, The University of Montana, Missoula, MT 59812, USA.
Safronetz D; Laboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Martellaro C; Laboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Rosenke K; Laboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Feldmann H; Laboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 11; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 11.
Typ publikacji:
Journal Article
MeSH Terms:
Orthohantavirus*
Ebolavirus*/genetics
Ebola Vaccines*
Cricetinae ; Animals ; Humans ; Vesiculovirus/genetics ; Vesicular stomatitis Indiana virus/genetics ; Glycoproteins ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Regulation of Ebola GP conformation and membrane binding by the chemical environment of the late endosome.
Autorzy:
Jain A; Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Govindan R; Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.; Medical Scientist Training Program, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Berkman AR; Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Luban J; Program in Molecular Medicine, UMass Chan Medical School, Worcester, Massachusetts, United States of America.; Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Díaz-Salinas MA; Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Durham ND; Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Munro JB; Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.; Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2023 Dec 06; Vol. 19 (12), pp. e1011848. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*
Ebolavirus*/physiology
Humans ; Calcium/metabolism ; Viral Envelope Proteins/metabolism ; Endosomes/metabolism ; Protein Conformation ; Virus Internalization ; Membrane Fusion ; Hydrogen-Ion Concentration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Performance of a safe and dignified burial intervention during an Ebola epidemic in the eastern Democratic Republic of the Congo, 2018-2019.
Autorzy:
Warsame A; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Eamer G; International Federation of Red Cross and Red Crescent Societies, Geneva, Switzerland.
Kai A; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Dios LR; International Federation of Red Cross and Red Crescent Societies, Geneva, Switzerland.
Rohan H; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Keating P; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.; UK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine, London, UK.
Katshishi J; Red Cross Society of the Democratic Republic of Congo, Kinshasa, Democratic Republic of the Congo.
Checchi F; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Dec 05; Vol. 21 (1), pp. 484. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hemorrhagic Fever, Ebola*/epidemiology
Hemorrhagic Fever, Ebola*/prevention & control
Ebolavirus*
Humans ; Democratic Republic of the Congo/epidemiology ; Retrospective Studies ; Disease Outbreaks/prevention & control ; Burial
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Emergence of deadly viral haemorrhagic fever disease outbreaks in West Africa.
Autorzy:
Vega-Rodriguez W; Department of Veterinary & Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Twin Cities, St Paul, MN, USA.
Ly H; Department of Veterinary & Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Twin Cities, St Paul, MN, USA.
Pokaż więcej
Źródło:
Virulence [Virulence] 2023 Dec; Vol. 14 (1), pp. 2176980.
Typ publikacji:
Editorial
MeSH Terms:
Hemorrhagic Fevers, Viral*/epidemiology
Ebolavirus*
Hemorrhagic Fever, Ebola*/epidemiology
Humans ; Lassa virus ; Africa, Western/epidemiology ; Disease Outbreaks
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sequence optimized diagnostic assay for Ebola virus detection.
Autorzy:
Koehler JW; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, MD, 20102, USA.
Stefan CP; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, MD, 20102, USA.
Hall AT; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, MD, 20102, USA.
Delp KL; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, MD, 20102, USA.
O'Hearn AE; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, MD, 20102, USA.
Taylor-Howell CL; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, MD, 20102, USA.
Wauquier N; Metabiota, Kenema, Sierra Leone.
Schoepp RJ; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, MD, 20102, USA.
Minogue TD; Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, Fort Detrick, MD, 20102, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 01; Vol. 13 (1), pp. 18840. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Ebolavirus*/genetics
Hemorrhagic Fever, Ebola*
Humans ; Africa, Western ; Disease Outbreaks ; Genomics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line.
Autorzy:
Aguilar-Briseño JA; Department of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
Elliff JM; Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242, USA.
Patten JJ; Department of Virology, Immunology, and Microbiology, National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA.
Wilson LR; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA.
Davey RA; Department of Virology, Immunology, and Microbiology, National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA.
Bailey AL; Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA.
Maury WJ; Department of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.; Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Oct 11; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Hemorrhagic Fever, Ebola*
Ebolavirus*/genetics
Animals ; Mice ; Interferon-gamma/pharmacology ; Kupffer Cells ; Interferons/pharmacology ; Antiviral Agents/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel Antiviral Molecules against Ebola Virus Infection.
Autorzy:
Collados Rodríguez M; School of Infection & Immunity (SII), College of Medical, Veterinary and Life Sciences (MVLS), Sir Michael Stoker Building, MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow G61 1QH, UK.; Unité Hépacivirus et Immunité Innée, CNRS, UMR 3569, Département de Virologie, Institut Pasteur, 75015 Paris, France.
Maillard P; Unité Hépacivirus et Immunité Innée, CNRS, UMR 3569, Département de Virologie, Institut Pasteur, 75015 Paris, France.
Journeaux A; Unit of Biology of Emerging Viral Infections, Institut Pasteur, 69007 Lyon, France.
Komarova AV; Interactomics, RNA and Immunity Laboratory, Institut Pasteur, 75015 Paris, France.; Unité de Génomique Virale et Vaccination, Institut Pasteur, 75015 Paris, France.; Université Paris Cité, 75013 Paris, France.
Najburg V; Unité de Génomique Virale et Vaccination, Institut Pasteur, 75015 Paris, France.; Université Paris Cité, 75013 Paris, France.
David RS; Unité de Génomique Virale et Vaccination, Institut Pasteur, 75015 Paris, France.; Blizard Institute-Faculty of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Helynck O; Unité de Chimie et Biocatalyse, CNRS, UMR 3523, Institut Pasteur, Université de Paris, 75015 Paris, France.
Guo M; CAS Key Laboratory of Molecular Virology and Immunology, Unit of Viral Hepatitis, Shanghai Institute of Immunity and Infection, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Shanghai 200023, China.
Zhong J; CAS Key Laboratory of Molecular Virology and Immunology, Unit of Viral Hepatitis, Shanghai Institute of Immunity and Infection, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Shanghai 200023, China.
Baize S; Unit of Biology of Emerging Viral Infections, Institut Pasteur, 69007 Lyon, France.
Tangy F; Unité de Génomique Virale et Vaccination, Institut Pasteur, 75015 Paris, France.; Université Paris Cité, 75013 Paris, France.
Jacob Y; Université Paris Cité, 75013 Paris, France.; Unité Génétique Moléculaire des Virus à ARN, CNRS, UMR 3569, Département de Virologie, Institut Pasteur, 75015 Paris, France.
Munier-Lehmann H; Unité de Chimie et Biocatalyse, CNRS, UMR 3523, Institut Pasteur, Université de Paris, 75015 Paris, France.
Meurs EF; Unité Hépacivirus et Immunité Innée, CNRS, UMR 3569, Département de Virologie, Institut Pasteur, 75015 Paris, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 30; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hemorrhagic Fever, Ebola*/drug therapy
Hemorrhagic Fever, Ebola*/metabolism
Ebolavirus*/physiology
Humans ; Animals ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Mammals
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Virucidal activity of three standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole blood.
Autorzy:
Jonsdottir HR; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland. .; Department of Rheumatology, Immunology, and Allergology, Inselspital University Hospital, Bern, Switzerland. .; Department of BioMedical Research, University of Bern, Bern, Switzerland. .
Zysset D; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland. .
Lenz N; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.; Institute of Microbiology, Lausanne University Hospital, University of Lausanne, 1011, Lausanne, Switzerland.; Agroscope, Federal Office for Agriculture, Bern, Switzerland.
Siegrist D; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Ruedin Y; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Ryter S; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Züst R; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Geissmann Y; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Ackermann-Gäumann R; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.; ADMED Microbiologie, La Chaux-de-Fonds, Switzerland.
Engler OB; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Weber B; Spiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 21; Vol. 13 (1), pp. 15718. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Disinfectants*/pharmacology
Ebolavirus*
Hemorrhagic Fever, Ebola*/prevention & control
Humans ; Disinfection ; Soil
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.
Autorzy:
Zola Matuvanga T; Tropical Medicine Department, University of Kinshasa, Kinshasa, Kinshasa, Democratic Republic of the Congo.; Vaccine and Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Antwerp, Belgium.; Department of Family Medicine and Population Health, Global Health Institute, University of Antwerp, Wilrijk, Antwerp, Belgium.
Mariën J; Department of Biology, Evolutionary Ecology Group, University of Antwerp, Wilrijk, Antwerp, Belgium.
Larivière Y; Vaccine and Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Antwerp, Belgium.; Department of Family Medicine and Population Health, Global Health Institute, University of Antwerp, Wilrijk, Antwerp, Belgium.
Osang'ir BI; Vaccine and Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Antwerp, Belgium.; Department of Family Medicine and Population Health, Global Health Institute, University of Antwerp, Wilrijk, Antwerp, Belgium.
Milolo S; Tropical Medicine Department, University of Kinshasa, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Meta R; Tropical Medicine Department, University of Kinshasa, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Esanga E; Division Provinciale de la Santé de la Tshuapa, Ministry of Health Hygiene and Prevention, Boende, Tshuapa, Democratic Republic of the Congo.
Maketa V; Tropical Medicine Department, University of Kinshasa, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Matangila J; Tropical Medicine Department, University of Kinshasa, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Mitashi P; Tropical Medicine Department, University of Kinshasa, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Ahuka Mundeke S; Department of Virology, Institut National de Recherches Biomedicales, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Muhindo-Mavoko H; Tropical Medicine Department, University of Kinshasa, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Muyembe Tamfum JJ; Department of Virology, Institut National de Recherches Biomedicales, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Van Damme P; Vaccine and Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Wilrijk, Antwerp, Belgium.
Van Geertruyden JP; Department of Family Medicine and Population Health, Global Health Institute, University of Antwerp, Wilrijk, Antwerp, Belgium.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 01; Vol. 18 (9), pp. e0286479. Date of Electronic Publication: 2023 Sep 01 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ebolavirus*
Hemorrhagic Fever, Ebola*
Ebola Vaccines*
Blood Group Antigens*
Animals ; Humans ; Democratic Republic of the Congo ; Seroepidemiologic Studies ; Health Personnel
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adipose Tissues from Human and Bat-Derived Cell Lines Support Ebola Virus Infection.
Autorzy:
Garnett L; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Tran KN; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Schiffman Z; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.; Department of Medical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Muise KA; Department of Biology and Centre for Forest Interdisciplinary Research, University of Winnipeg, Winnipeg, MB R3B 2E9, Canada.
Fletcher QE; Department of Biology and Centre for Forest Interdisciplinary Research, University of Winnipeg, Winnipeg, MB R3B 2E9, Canada.
Dzal YA; Department of Biology and Centre for Forest Interdisciplinary Research, University of Winnipeg, Winnipeg, MB R3B 2E9, Canada.
Leung A; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Albietz A; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Warner BM; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Griffin BD; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Kobasa D; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.; Department of Medical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Willis CKR; Department of Biology and Centre for Forest Interdisciplinary Research, University of Winnipeg, Winnipeg, MB R3B 2E9, Canada.
Strong JE; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.; Department of Medical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.; Pediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Aug 29; Vol. 15 (9). Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hemorrhagic Fever, Ebola*
Chiroptera*
Ebolavirus*/physiology
Animals ; Humans ; Ecosystem ; Adipose Tissue ; Cell Line
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 2113

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies